Christopher J. Schofield, D.Phil.

Affiliations:

1982-

Chemistry

University of Oxford, Oxford, United Kingdom

Area:

Enzymes

grad student

1982-1985

Oxford

Children

Nick Westwood	grad student
Jasmin Mecinović	grad student	2005-2009	Oxford
Christoph Loenarz	grad student	2010	Oxford
André U. Augustin	grad student	2014-2015	Oxford
Robert K Leśniak	grad student	2012-2016	Oxford
Corentin Bon	grad student	2017-2017	Oxford University UK
Biswadip Banerji	post-doc		Oxford
Jose Castellanos	post-doc		Oxford
Rasheduzzaman Chowdhury	post-doc		Oxford
Ian Clifton	post-doc		Oxford
Refaat Hamed	post-doc		Oxford
Adam Hardy	post-doc		Oxford
Lars Hillringhaus	post-doc		Oxford
Akane Kawamura	post-doc		Oxford
Oliver King	post-doc		Oxford
Clarisse Lejeune	post-doc		Oxford
Mukram Mackeen	post-doc		Oxford
Marios S. Markoulides	post-doc		Oxford
Michael McDonough	post-doc		Oxford
Nathan Rose	post-doc		Oxford
Elena Sanchez	post-doc		Oxford
Alexander Wolf	post-doc		Oxford
Esther Woon	post-doc		Oxford
Christopher Lohans	post-doc	2015-	Oxford
Monisha Singha	post-doc	2022-	Oxford
Jürgen Seibel	post-doc	2000-2002	Oxford
John L. Sorensen	post-doc	2003-2006	Oxford

Collaborators

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Belle R, Saraç H, Salah E, et al. (2024) Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2-Hydroxyglutarate. Journal of Medicinal Chemistry
Šimelis K, Saraç H, Salah E, et al. (2024) Selective targeting of human TET1 by cyclic peptide inhibitors: Insights from biochemical profiling. Bioorganic & Medicinal Chemistry. 99: 117597
Corner TP, Teo RZR, Wu Y, et al. (2023) Structure-guided optimisation of -hydroxythiazole-derived inhibitors of factor inhibiting hypoxia-inducible factor-α. Chemical Science. 14: 12098-12120
Brewitz L, Nakashima Y, Piasecka SK, et al. (2023) 5-Substituted Pyridine-2,4-dicarboxylate Derivatives Have Potential for Selective Inhibition of Human Jumonji-C Domain-Containing Protein 5. Journal of Medicinal Chemistry
Figg WD, Fiorini G, Chowdhury R, et al. (2023) Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2. Proteins
Tumber A, Salah E, Brewitz L, et al. (2023) Kinetic and inhibition studies on human Jumonji-C (JmjC) domain-containing protein 5. Rsc Chemical Biology. 4: 399-413
Miura T, Malla TR, Owen CD, et al. (2023) In vitro selection of macrocyclic peptide inhibitors containing cyclic γ-amino acids targeting the SARS-CoV-2 main protease. Nature Chemistry
Türkmen VA, Hintzen JCJ, Tumber A, et al. (2023) Substrate selectivity and inhibition of histidine JmjC hydroxylases MINA53 and NO66. Rsc Chemical Biology. 4: 235-243
Bonnici J, Oueini R, Salah E, et al. (2023) The catalytic domains of all human KDM5 JmjC demethylases catalyse N-methyl arginine demethylation. Febs Letters
Belle R, Kamps JJAG, Poater J, et al. (2022) Reading and erasing of the phosphonium analogue of trimethyllysine by epigenetic proteins. Communications Chemistry. 5: 27

Christopher J. Schofield, D.Phil.

Affiliations:

Area:

Website:

Google:

Mean distance: 7.48

Parents

Children

Collaborators

Publications